Intrigued by the case of Orphacol, a medicine developed to treat an orphan disease, members of the European Parliament’s Committee on the Environment and Public Health (ENVI) asked the European Commission to present explanations, on 21 June. A new...
Identification
Bonjour, l'accès à cet article est réservé aux abonnés. Veuillez vous identifier dans le cadre ci-dessous.
Commission to introduce mandatory accessibility features - 04/12/2012
Dalli affair: MEPs call for explanation - 04/12/2012
Commission to introduce mandatory accessibility features - 
